
WHO still seeking COVID-19 origin, says all scenarios ‘remain on the table'
The World Health Organization says its probe into the origins of the SARS-CoV-2 virus, which caused the COVID-19 pandemic, is still ongoing, and despite a three-year investigation, has yet to find the exact cause.
'As things stand, all hypotheses must remain on the table, including zoonotic spillover and lab leak,' WHO director-general Tedros Adhanom Ghebreyesus said during a press briefing Friday.
His comments came after a report published Friday from the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), which said 'available evidence' supports the hypothesis that the coronavirus jumped from animals to humans, likely from bats 'or through an intermediate host,' through a process called zoonotic spillover.
SAGO is a panel of 27 independent, international, multidisciplinary experts formed by the World Health Organization to advise on technical and scientific considerations regarding emerging and re-emerging pathogens, like COVID-19.
Story continues below advertisement
'While most available and accessible published scientific evidence supports hypothesis #1, zoonotic transmission from animals, possibly from bats or an intermediate host to humans, SAGO is not currently able to conclude exactly when, where and how SARS-CoV-2 first entered the human population,' the report reads.
It notes the closest known 'precursor strains' were identified in bats in China and the Lao People's Democratic Republic, but says the strains are too distantly related to the virus to be the direct source of the pandemic.
The report notes that some of the difficulty in determining a cause is due to China not having shared certain information, which also has made it difficult to examine the second hypothesis suggesting an accidental lab leak.
The WHO requested the country share hundreds of genetic sequences from individuals with COVID-19 early in the pandemic, as well as more detailed information about the animals sold at markets in Wuhan, and information on work done and biosafety conditions at laboratories in Wuhan.
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy
'To date, China has not shared this information either with SAGO or WHO,' a news release says.
Marietjie Venter, the chair of the group, said on Friday during a press briefing that without the necessary data, it could not evaluate if the virus was the result of a lab accident.
'Therefore, this hypothesis could not be investigated or excluded,' Venter said. 'It was deemed to be very speculative, based on political opinions and not backed up by science.'
Story continues below advertisement
That hypothesis is one U.S. President Donald Trump has repeatedly suggested as the cause, though a U.S. intelligence analysis found there was insufficient evidence to prove the theory.
1:57
WHO says COVID-19 origins still under investigation despite recent reports
Two other hypotheses were also provided in the report, the first being the introduction of the virus into animal markets via 'cold chain processes' and subsequent infection in humans through contact with products sold at the market.
Venter said no added evidence has become available to support the hypothesis and more data is needed to prove it.
The last hypothesis, involving deliberate manipulation of the virus in a laboratory, followed by a biosafety breach, remains unsupported, with Venter noting that SAGO examined the genome structure of the virus and any related publications and reports but found no evidence to support it.
All four hypotheses will be re-evaluated if further information becomes available, but Venter said the first related to zoonotic spillover is considered the supported hypothesis.
Story continues below advertisement
'Until more scientific data becomes available, the origins of how SARS-CoV-2 entered human populations will remain inconclusive,' she said.
Ghebreyesus recognized during the briefing that the task of investigating the cause was difficult, and told reporters that members of SAGO have not all agreed on everything, which is 'to be expected.'
He said earlier this week that one member of the team resigned and three others asked for their names to be removed from the report.
Ghebreyesus went on to express concerns that China had not provided further information and encouraged it, as well as other governments he said have conducted COVID-19 investigations, to provide this data.
Last year, The Associated Press found that the Chinese government had frozen meaningful domestic and international efforts to trace the virus's origins in the first weeks of the outbreak in 2020, and that the WHO may have missed early opportunities to investigate how the pandemic began.
Chinese officials have repeatedly dismissed the idea the pandemic could have started in a lab, saying the search should be conducted in other countries.
Last September, researchers zeroed in on a short list of animals they think might have spread COVID-19 to humans, including raccoon dogs, civet cats and bamboo rats.
— with files from The Associated Press
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Global News
6 hours ago
- Global News
Alberta strikes deal to off-load remaining controversial children's pain medicine
Three years after Alberta's government paid $70 million for children's pain and fever medicine, its front-line health provider says it has worked out a deal to off-load what remains of the controversial stockpile. Alberta Health Services spokeswoman Kristi Bland, in a Friday statement, confirmed the medicine is being donated to the charity group Health Partners International of Canada to distribute to 'vulnerable communities worldwide.' 'Preliminary shipments of products have started to leave Alberta, and additional shipments will happen in the coming months,' she wrote. Jackie Cousins, president of Health Partners, said the group works with others to ship medicine where it is needed, and that donations of medicine could end up in more than one country. In an email, she said some of the Alberta medicine would be sent to war-torn Ukraine. Story continues below advertisement 1:46 Alberta government looks to recoup $80M from children's medicine shipment The medication has proven to be problematic for Premier Danielle Smith's government. It struck a deal for the medicine three years ago to fill a gap during the COVID-19 pandemic. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Alberta paid $70 million to MHCare Medical for the medication in 2022 during a countrywide shortage. The province only received about 30 per cent of the shipment, and it has sat on 1.4 million bottles since the spring of 2023 after front-line health staff reported problems, including that the medicine's thicker consistency risked clogging feeding tubes. View image in full screen The government of Alberta paid more than $70 million for 1.4 million bottles of children's pain medicine in 2022, during a countrywide shortage, but was forced to stop distributing the medicine when health care workers raised safety concerns. Government of Alberta At an unrelated news conference Friday, Opposition NDP finance critic Court Ellingson said the government 'refuses' to take responsibility for the medicine and has 'no plan' to recoup funds. Story continues below advertisement 'That somebody is able to make use of this Tylenol somewhere, I'm going to say that that is a good thing, but there are so many other challenges there,' he said. '(Smith's government members) need to acknowledge that they were the ones that made these inappropriate decisions, that we're still on the hook for (product) — that we did not get product, and we don't know if that money is coming back.' Smith hinted in March that her government was working on a deal to send scores of the medication elsewhere. At that time, then-health minister Adriana LaGrange called the medications 'good quality drugs' and said it bothered her that they were going unused. The government has said it's still looking to get its money's worth by working with MHCare to import other medications to fulfill the $70-million deal. 0:40 Alberta Health Minister confirms new procurement of children's medicine will be at average retail price MHCare has since became embroiled in a provincial contracting and conflict of interest scandal after the former head of Alberta Health Services filed a wrongful dismissal lawsuit against the province. Story continues below advertisement In the lawsuit, which hasn't been tested in court, Athana Mentzelopoulos alleges she was fired for looking into inflated government contracts awarded to private surgical companies. The lawsuit mentions MHCare multiple times, but the company is not named as a defendant. MHCare has said any allegations of wrongdoing on its part are 'unwarranted and unjustified.' The allegations have prompted numerous internal and external investigations, including by the RCMP.


Calgary Herald
6 hours ago
- Calgary Herald
Training exercise at CFB Suffield faces down the invisible, lethal enemy
It can be a bit unnerving for a civilian to see military personnel in hazmat suits walking around, even if a person knows those involved are only running training exercises. Article content Over about three weeks this June, the Canadian Armed Forces led annual chemical, biological, radiological and nuclear training — Exercise Precise Response — at CFB Suffield near Medicine Hat. Article content Article content Article content The live agent training exercise was directed by Defence Research and Development Canada on behalf of NATO. Article content Article content The exercise involved about 475 participants, representing 12 NATO allies and partner countries. The flags of several NATO nations, including Canada, Great Britain and Germany, were seen flying at the Precise Response training ground as participants trained, tested and coordinated decontamination capabilities during realistic CBRN scenarios. Article content For those involved, hazmat suits are just part of the job, like steel-toed boots and a hard hat at a construction site, said Lt.-Col Trevor Waaga, the exercise director. 'It's just part of the equipment to keep the individual safe,' Waaga said during an interview Wednesday with Postmedia. Article content The origins of this chemical, biological, radiological and nuclear training on Canadian soil came out of the November 2022 NATO Prague Summit, which led to the establishment of the NATO CBRN Defence Battalion, a unit that forms part of the NATO Response Force. Article content Article content As part of its contribution, Canada offered to host three weeks of annual live agent training in support of the CBRN Battalion, which includes a wide variety of assets from several countries that run specific CBRN defence activities in support of NATO operations. Article content The Precise Response exercise began in 2004, and Canada has hosted the training each year since at Suffield, except for two years during the COVID-19 pandemic. Over the years, Precise Response has hosted approximately 4,000 chemical, biological, radiological and nuclear specialists from allied and partner countries. Article content This year's Canadian contingent included 40 members of the 5 Canadian Mechanized Brigade Group's Decontamination Platoon, along with reservists from across the country. The Decontamination Platoon provides chemical, biological and radiological decontamination for vehicles, equipment, and personnel, including those injured.

CBC
7 hours ago
- CBC
U.S. vaccine panel rejects flu shots with a specific preservative, despite safety data
The Trump administration's new vaccine advisers on Thursday endorsed this fall's flu vaccinations for just about every American — but only if they use certain shots free of a preservative that has been safely used in vaccines for decades. What is normally a routine step in preparing for the upcoming flu season drew intense scrutiny after U.S. Health Secretary Robert F. Kennedy Jr. abruptly fired the influential 17-member Advisory Committee on Immunization Practices (ACIP)and handpicked replacements that include several vaccine skeptics. The seven-member panel bucked another norm Thursday as it discussed the safety of a preservative used in less than five per cent of U.S. flu vaccinations: It deliberated based only on a presentation from an anti-vaccine group's former leader — without allowing the usual public airing of scientific data from the U.S. Centers for Disease Control and Prevention. The preservative, thimerosal, has been used for decades in certain vaccines that come in multi-dose vials, to prevent contamination as each dose is withdrawn. Its controversy stems from containing a small amount of a particular type of mercury. However, the CDC's own data shows it is safe, and on Friday the World Health Organization stated in a press briefing that there was no evidence of risk. "Thimerosal has been reviewed multiple times by multiple agencies, including WHO, and it's clear from the evidence that there is no evidence of harm from the use of thimerosal," Dr. Katherine O'Brien from WHO told reporters in reaction to the U.S. panel decision. Thimerosal contains a minute amount of ethyl mercury, which breaks down quickly in the body and is swiftly removed, unlike methyl mercury, the type of mercury found in the environment which can build up in the body and cause harm. In Canada, a handful of multi-dose influenza vaccines approved for use by Health Canada contain thimerosal, but the vast majority of routine childhood vaccines do not. Single-dose flu shots unaffected Study after study has found no evidence that thimerosal causes autism, a myth long pushed by anti-vaccine groups, or poses any safety risks. Yet since 2001, all vaccines routinely used for U.S. children age 6 years or younger have already come in thimerosal-free formulas. The advisory panel voted to back the usual U.S. recommendation that nearly everyone age six months and older get an annual flu vaccination, but then voted 5-1 with one abstention that these had to be thimerosal-free formulations. This would include single-dose shots that already are the most common type of flu vaccination, and would rule out the subset of flu vaccine dispensed in multi-dose vials. "There is still no demonstrable evidence of harm," one panelist, Dr. Joseph Hibbeln, a psychiatrist formerly with the National Institutes of Health, said in acknowledging the committee wasn't following its usual practice of acting on evidence. But he argued that "we have to respect the fear of mercury" that he said might dissuade some people from getting vaccinated. Panel blocked CDC's analysis Lyn Redwood, formerly of the Kennedy-founded anti-vaccine group Children's Health Defense, gave the presentation on thimerosal in front of the panel, arguing that it was a neurotoxin. The version of Redwood's presentation posted to the CDC's website earlier this week initially included a reference to a study that does not exist. The report she gave to the committee was significantly shorter, removing a reference to that study and another slide saying she did not have any conflicts of interest. "With the vote on thimerosal this afternoon, the new committee has turned the ACIP process into a farce," said former CDC vaccine adviser Dr. Fiona Havers, who resigned last week over Kennedy's changes to vaccine policy. Medical groups decried the panel's lack of transparency in blocking a CDC analysis of thimerosal that concluded there was no link between the preservative and neurodevelopmental disorders, including autism. The data had been posted on the committee's website Tuesday, but was later removed — because, according to ACIP member Dr. Robert Malone, the report hadn't been authorized by Kennedy's office. Panel members said they had read it. The ACIP helps the CDC determine who should be vaccinated against a long list of diseases, and when, and its recommendations have a big impact on availability and insurance coverage of vaccines in the U.S. Normally the CDC's director would decide whether to accept ACIP's recommendation, but the Senate has not yet confirmed nominee Susan Monarez. Administration officials said Kennedy would make that decision. While Thursday's debate involved only a small fraction of flu vaccines, some public health experts contend the discussion unnecessarily raised doubt about vaccine safety. Already, fewer than half of Americans get their yearly flu vaccinations, and mistrust in vaccines overall is growing. "Selective use of data and omission of established science undermines public trust and fuels misinformation," said Dr. Sean O'Leary of the American Academy of Pediatrics (AAP). He said of the new panelists, "Nothing about their recent actions have been science-based or transparent." WATCH: Misinformation one of the factors behind decline in childhood vaccination globally: Decline in childhood vaccination fuelled by global conflicts, misinformation: Lancet 3 days ago Duration 2:01 A new study published in the Lancet medical journal suggests childhood vaccinations have stagnated or declined since 2010. The authors say geopolitical instability is fuelling the drop in some countries, but misinformation is largely driving the decline in high-income countries. The pediatrics group announced Wednesday that it would no longer be participating in the ACIP meetings, with president Sue Kressly saying in a video statement that "with the committee dismissals, it is no longer a credible process." The AAP will continue publishing its own vaccination recommendations. The flu votes marked the final step of a two-day meeting that alarmed pediatricians and other doctors' groups, who pointed to new panelists' lack of expertise in how to properly track vaccine safety — and a shift in focus which appears to boost anti-vaccine messaging. Of special concern was the announcement by panel chairman Martin Kulldorff to reevaluate the "cumulative effect" of the children's vaccine schedule — the list of immunizations given at different times throughout childhood. That reflects the scientifically debunked notion that children today get too many vaccinations for their immune systems.